Related Experiment Videos
Sounding board. Regression of neuroblastoma IV-S: a genetic hypothesis
The New England Journal of Medicine
|May 29, 1980
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pathways Linking Treatment Intensity and Psychosocial Outcomes among Adult Survivors of Childhood Leukemia.
Journal of health psychology·2011
Two genetic hits (more or less) to cancer.
Nature reviews. Cancer·2002
Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma).
Archives of ophthalmology (Chicago, Ill. : 1960)·2001
Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG-5912.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Oveporexton for Narcolepsy Type 1 - Results from Two Phase 3 Trials.
The New England journal of medicine·2026
Tozorakimab to Prevent COPD Exacerbations.
The New England journal of medicine·2026
Familial short stature: genetic architecture, risk stratification, and precision management.
Frontiers in endocrinology·2026
Shared genetic architecture between DTI-ALPS traits and neurodegenerative diseases.
Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
[Analysis of clinical phenotypes and pathogenicity of a c.4476+5G>T variant of SCN1A gene in a Chinese pedigree affected with Genetic epilepsy with febrile seizures plus].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics·2026
APOL1 kidney disease: a critical narrative review of molecular mechanisms, clinical heterogeneity, and the emerging therapeutic landscape.
International urology and nephrology·2026
Longitudinal Characterization of Giant ANK2-Depleted Monkeys Suggests Neurodevelopmental-Disorder-Like Phenotypes.
Research (Washington, D.C.)·2026